Cargando…
Intratumor heterogeneity and tissue distribution of KRAS mutation in non-small cell lung cancer: implications for detection of mutated KRAS oncogene in exhaled breath condensate
PURPOSE: Mutated KRAS oncogene in exhaled breath condensate (EBC) can be a genetic marker of non-small cell lung cancer (NSCLC). However, a possibility of inhomogeneous distribution in cancer tissue and intratumor heterogeneity of KRAS mutation may decrease its significance. We investigated a status...
Autores principales: | Kordiak, Jacek, Szemraj, Janusz, Grabska-Kobylecka, Izabela, Bialasiewicz, Piotr, Braun, Marcin, Kordek, Radzisław, Nowak, Dariusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325989/ https://www.ncbi.nlm.nih.gov/pubmed/30368666 http://dx.doi.org/10.1007/s00432-018-2779-1 |
Ejemplares similares
-
Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction
por: Ito, Reina E., et al.
Publicado: (2021) -
KRAS insertion mutations are oncogenic and exhibit distinct functional properties
por: White, Yasmine, et al.
Publicado: (2016) -
No evidence of enhanced oxidant production in blood obtained from patients with obstructive sleep apnea
por: Grabska-Kobylecka, Izabela, et al.
Publicado: (2008) -
Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer
por: Rosell, Rafael, et al.
Publicado: (2023) -
Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer
por: Sánchez-Muñoz, Alfonso, et al.
Publicado: (2010)